Palmetto Issues Positive Final LCD for MDxHealth Prostate Cancer Test

Palmetto GBA has issued a positive final Local Coverage Determination to expand Medicare coverage for the firm’s ConfirmMDx for Prostate Cancer test.  The LCD expands Medicare coverage of the test to all Medicare providers effective Sept. 3.  The prior LCD, first established in 2014, limited coverage to only those providers enrolled in a certification and training registry program. The new LCD removes other conditions to continue Medicare coverage by deleting references to the Pascual clinical study, removing patient number limitations, and eliminating certain other conditions associated with the former MolDX coverage with data development program.

Source: https://www.genomeweb.com/reimbursement/palmetto-issues-positive-final-lcd-mdxhealth-prostate-cancer-test?utm_source=Sailthru&utm_medium=email&utm_campaign=Scan%20Mon%202018-07-23&utm_term=The%20Scan%20Bulletin